vida: extract claims from 2026-05-01-bls-multistate-state-behavioral-health-legislative-trends-2025

- Source: inbox/queue/2026-05-01-bls-multistate-state-behavioral-health-legislative-trends-2025.md
- Domain: health
- Claims: 0, Entities: 0
- Enrichments: 4
- Extracted by: pipeline ingest (OpenRouter anthropic/claude-sonnet-4.5)

Pentagon-Agent: Vida <PIPELINE>

domains/health/glp1-employer-coverage-declining-despite-utilization-growth-creating-access-gap.md

@@ -46,3 +46,10 @@ The FDA's April 2026 clarification targeted combination formulations (semaglutid
 **Source:** KFF 2025, Mercer 2026, DistilINFO via NPR
 
 Reconciliation of apparent contradiction: KFF shows 49% large employer coverage (up from 44%), Mercer shows 90% large employer retention, yet DistilINFO confirms 22% decline in total covered lives. The resolution: large employers (500+) are stable/expanding while smaller employers, health systems, state plans, and regional payers withdraw coverage. The net effect is population-level coverage decline despite large-employer stability. This confirms the bifurcation pattern where employer size predicts coverage persistence.
+
+
+## Supporting Evidence
+
+**Source:** NPR April 22, 2026; Mercer 2026
+
+NPR provides second-source confirmation of the covered lives decline: 3.6M (2024) → 2.8M (2026), a 22% drop. Multiple employers in NPR focus groups reported firms 'will no longer cover GLP-1 agonists for weight loss.' The Mercer data shows 66% of employers say GLP-1 had 'significant' impact on prescription drug spending, and 77% of large employers prioritize managing GLP-1 costs. This confirms the access gap is widening despite clinical demand growth.

domains/health/glp1-payer-fiscal-unsustainability-10x-pmpm-increase-2023-2024.md

@@ -11,7 +11,7 @@ sourced_from: health/2026-04-23-icer-glp1-affordable-access-2025.md
 scope: structural
 sourcer: ICER
 supports: ["glp-1-receptor-agonists-require-continuous-treatment-because-metabolic-benefits-reverse-within-28-52-weeks-of-discontinuation", "medicaid-glp1-coverage-reversing-through-state-budget-pressure"]
-related: ["glp-1-receptor-agonists-are-the-largest-therapeutic-category-launch-in-pharmaceutical-history-but-their-chronic-use-model-makes-the-net-cost-impact-inflationary-through-2035", "medicaid-glp1-coverage-reversing-through-state-budget-pressure", "glp-1-access-structure-inverts-need-creating-equity-paradox", "GLP-1 receptor agonists are the largest therapeutic category launch in pharmaceutical history but their chronic use model makes the net cost impact inflationary through 2035", "glp1-access-follows-systematic-inversion-highest-burden-states-have-lowest-coverage-and-highest-income-relative-cost", "glp1-year-one-persistence-doubled-2021-2024-supply-normalization", "glp1-payer-fiscal-unsustainability-10x-pmpm-increase-2023-2024", "glp1-behavioral-mandate-rate-tripled-2024-2025-signaling-managed-access-infrastructure-shift"]
+related: ["glp-1-receptor-agonists-are-the-largest-therapeutic-category-launch-in-pharmaceutical-history-but-their-chronic-use-model-makes-the-net-cost-impact-inflationary-through-2035", "medicaid-glp1-coverage-reversing-through-state-budget-pressure", "glp-1-access-structure-inverts-need-creating-equity-paradox", "GLP-1 receptor agonists are the largest therapeutic category launch in pharmaceutical history but their chronic use model makes the net cost impact inflationary through 2035", "glp1-access-follows-systematic-inversion-highest-burden-states-have-lowest-coverage-and-highest-income-relative-cost", "glp1-year-one-persistence-doubled-2021-2024-supply-normalization", "glp1-payer-fiscal-unsustainability-10x-pmpm-increase-2023-2024", "glp1-behavioral-mandate-rate-tripled-2024-2025-signaling-managed-access-infrastructure-shift", "glp1-employer-coverage-declining-despite-utilization-growth-creating-access-gap"]
 ---
 
 # GLP-1 obesity coverage creates acute payer fiscal crisis with employer plans experiencing >10x PMPM cost increases in 2023-2024 and major insurers reporting operating losses driven primarily by GLP-1 expenditures
@@ -38,3 +38,10 @@ Evernorth EncircleRx reports ~$200 million saved since 2024 across 9 million enr
 **Source:** DistilINFO April 2026
 
 Blue Cross Blue Shield Michigan reported $350M increase in GLP-1 drug costs in 2023 alone. Blue Cross Blue Shield Massachusetts reported $400M operating loss in 2024 driven largely by GLP-1 spending. These are major regional Blues plans with broad population coverage, confirming the fiscal unsustainability is affecting diverse payer types, not just large employers.
+
+
+## Supporting Evidence
+
+**Source:** NPR April 22, 2026; Mercer 2026
+
+One employer in the NPR article reported GLP-1 weight-loss spending increasing 50% year over year, corroborating the fiscal unsustainability finding. Mercer reports 59% of the largest employers (5,000+ workers) say GLP-1 costs exceeded expectations, and 66% report 'significant' impact on prescription drug spending. This confirms the cost trajectory is forcing payer responses.

domains/health/mental-health-parity-index-documents-43-states-structural-access-disparities-driven-by-below-medicare-reimbursement.md

@@ -11,9 +11,16 @@ sourced_from: health/2026-05-01-kennedy-forum-ama-mental-health-parity-index-nat
 scope: structural
 sourcer: Kennedy Forum + AMA + American Psychological Foundation + Ballmer Group
 supports: ["mhpaea-enforcement-closes-coverage-gaps-but-not-access-gaps-because-payers-differentially-treat-mental-health-versus-medical-reimbursement-rates", "the-mental-health-supply-gap-is-widening-not-closing-because-demand-outpaces-workforce-growth-and-technology-primarily-serves-the-already-served-rather-than-expanding-access"]
-related: ["mental-health-reimbursement-27pct-gap-structural-access-barrier", "mhpaea-enforcement-closes-coverage-gaps-but-not-access-gaps-because-payers-differentially-treat-mental-health-versus-medical-reimbursement-rates", "state-mhpaea-enforcement-addresses-procedural-parity-not-reimbursement-parity", "the-mental-health-supply-gap-is-widening-not-closing-because-demand-outpaces-workforce-growth-and-technology-primarily-serves-the-already-served-rather-than-expanding-access"]
+related: ["mental-health-reimbursement-27pct-gap-structural-access-barrier", "mhpaea-enforcement-closes-coverage-gaps-but-not-access-gaps-because-payers-differentially-treat-mental-health-versus-medical-reimbursement-rates", "state-mhpaea-enforcement-addresses-procedural-parity-not-reimbursement-parity", "the-mental-health-supply-gap-is-widening-not-closing-because-demand-outpaces-workforce-growth-and-technology-primarily-serves-the-already-served-rather-than-expanding-access", "mhpaea-enforcement-evolved-three-levels-coverage-access-metrics-reimbursement"]
 ---
 
 # The Mental Health Parity Index documents that 43 states have structural access disparities in commercial insurance driven by below-Medicare reimbursement rates, not just coverage design failures
 
 The Mental Health Parity Index launched nationally on April 14, 2026, documenting that 43 of 50 states show structural disparities in access to in-network mental health and substance use disorder treatment relative to physical health care. The Index's key methodological contribution is benchmarking commercial insurance reimbursement rates to Medicare payment rates, revealing that the majority of clinicians providing MH/SUD treatment are paid LESS than clinicians providing physical health treatment. This reimbursement differential is documented as a driver of lower in-network participation. The tool visualizes how insurance contract data relate to access disparities at the county level, with 7 in 10 counties facing similar access disparities locally. Illinois piloted the Index after signing a mental health parity bill into law, creating a natural experiment for outcome-based enforcement. The Index provides the measurement infrastructure that outcome-based parity monitoring would require, operationalizing the reimbursement differential at state and county level using Medicare payment benchmarks. The 43-state finding suggests no state has effectively solved the reimbursement differential problem through current MHPAEA enforcement mechanisms, confirming the two-level access problem is structural rather than enforcement-dependent.
+
+
+## Supporting Evidence
+
+**Source:** MultiState Aug 2025, Oregon parity report
+
+Oregon's fourth annual parity report (2025) identified persistent disparities in claims denials, reimbursement, and utilization review for mental health versus medical/surgical care. Many health plans have significantly fewer in-network mental health providers compared to medical/surgical providers, resulting in longer wait times. This confirms that structural access disparities persist even in states with active parity monitoring.

domains/health/state-mhpaea-enforcement-addresses-procedural-parity-not-reimbursement-parity.md

@@ -46,3 +46,17 @@ Illinois's enforcement of the 2024 Final Rule's outcome data evaluation requirem
 **Source:** Illinois Mental Health Parity Index pilot, Kennedy Forum 2024-2026
 
 Illinois piloted the Mental Health Parity Index after signing a mental health parity bill into law, creating a natural experiment for outcome-based enforcement. The Index provides measurement infrastructure enabling state regulators to enforce reimbursement parity through Medicare payment rate benchmarking, independent of federal enforcement posture.
+
+
+## Extending Evidence
+
+**Source:** MultiState legislative tracking database, Aug 2025
+
+29 states enacted 75 behavioral health parity bills in 2025, representing the broadest state legislative response to federal enforcement withdrawal. This includes not just enforcement actions but coverage mandates, utilization review consistency requirements (Alaska, Oklahoma, Washington), and outcome data collection mandates (West Virginia). The scale indicates state enforcement compensation is a structural phenomenon across a majority of states, not isolated actions by a few aggressive commissioners.
+
+
+## Extending Evidence
+
+**Source:** MultiState Aug 2025, Becker's Behavioral Health
+
+State enforcement is bipartisan: Georgia's $25M enforcement (largest in US history) was conducted by a Republican commissioner, while Washington's enforcement was led by a Democrat commissioner. This bipartisan pattern suggests state enforcement compensation is driven by structural healthcare access failures rather than partisan ideology, increasing the durability of the trend.

inbox/archive/health/2026-04-22-npr-glp1-coverage-decline-insurance-slipping-2026.md

@@ -7,10 +7,13 @@ date: 2026-04-22
 domain: health
 secondary_domains: []
 format: thread
-status: unprocessed
+status: processed
+processed_by: vida
+processed_date: 2026-05-01
 priority: high
 tags: [GLP-1, obesity, employer-coverage, covered-lives, insurance-access, cost-crisis, Wegovy, Zepbound]
 intake_tier: research-task
+extraction_model: "anthropic/claude-sonnet-4.5"
 ---
 
 ## Content

inbox/archive/health/2026-05-01-bls-multistate-state-behavioral-health-legislative-trends-2025.md

@@ -7,10 +7,13 @@ date: 2025-08-26
 domain: health
 secondary_domains: []
 format: thread
-status: unprocessed
+status: processed
+processed_by: vida
+processed_date: 2026-05-01
 priority: medium
 tags: [mental-health-parity, MHPAEA, state-legislation, behavioral-health, parity-enforcement, workforce-shortage, bipartisan]
 intake_tier: research-task
+extraction_model: "anthropic/claude-sonnet-4.5"
 ---
 
 ## Content